-
AI Framework from University of Sheffield and AstraZeneca Enhances Protein Design for Drug Development
17 Jun 2025 23:05 GMT
… at the University of Sheffield, AstraZeneca, and the University of Southampton … Bai, Senior Machine Learning Scientist, AstraZeneca, Ph.D., AI, University of … earlier work between Sheffield and AstraZeneca, including the development of DrugBAN …
-
Cutaneous Lupus Erythematosus Market Research Report 2025-2035, Competitive Analysis of Biogen, Bristol-Myers Squibb, Sanofi, AstraZeneca, Gilead Sciences, and Kyowa Kirin - ResearchAndMarkets.com
17 Jun 2025 14:57 GMT
…
Biogen
Bristol-Myers Squibb
Sanofi
AstraZeneca
Gilead Sciences
Kyowa Kirin Co …
-
Astrazeneca makes $5.3B drug R&D pact with CSPC
16 Jun 2025 23:09 GMT
… $5.33 billion deal with Astrazeneca plc to develop novel preclinical …
-
AstraZeneca touts early Ultomiris survival data in children living with rare post-transplant complication
16 Jun 2025 16:09 GMT
… indications of its predecessor Soliris, AstraZeneca is eyeing new avenues for … and 26% in adults, AstraZeneca added.
AstraZeneca’s latest study results covered … indications held by its predecessor.
AstraZeneca has previously communicated blockbuster sales …
-
British-Swedish AstraZeneca has entered into a strategic partnership with China's CSPC Pharmaceuticals
16 Jun 2025 15:32 GMT
… 16 June 2025 17:45
AstraZeneca plc, a British-Swedish … in a press release from AstraZeneca.
As part of the … . At the same time, AstraZeneca will retain the exclusive rights … s facilities in Shijiazhuang (China).
AstraZeneca is a British—Swedish multinational …
-
CSPC and Astrazeneca establish strategic research collaboration
16 Jun 2025 15:25 GMT
… strategic research collaboration agreement with Astrazeneca plc for the discovery and …
-
EHA 2025: AstraZeneca’s surovatamig is potential next-gen BiTE for R/R B-ALL
16 Jun 2025 14:12 GMT
… , pharmacokinetics and clinical activity of AstraZeneca’s surovatamig, a next-generation …
-
AstraZeneca and CSPC Pharmaceuticals enter AI-driven partnership worth $5.3bn
16 Jun 2025 12:06 GMT
AstraZeneca (AZ) and CSPC Pharmaceuticals Group …
-
AstraZeneca signs $5.2bn deal to develop drugs for chronic disease with Chinese biotech
15 Jun 2025 17:08 GMT
-
AstraZeneca signs multibillion-pound agreement with Chinese biotech firm CSPC to develop AI-powered treatments in Beijing
14 Jun 2025 17:52 GMT
… major game-changer.
And AstraZeneca, the UK’s largest … out of the gate, AstraZeneca is handing over £81 million … have been released, and AstraZeneca executives have remained tight-lipped … revolutionize drug development, and AstraZeneca wants to be at the …